NCT03271593 is a clinical trial of No intervention in Gastroenteritis, sponsored by GlaxoSmithKline.

Who is sponsoring NCT03271593?

NCT03271593 is sponsored by GlaxoSmithKline.

What drugs are being tested in NCT03271593?

Interventions in NCT03271593: No intervention.

What condition does NCT03271593 study?

NCT03271593 studies Gastroenteritis.

Is NCT03271593 still recruiting?

NCT03271593 is currently completed. Last updated 21 September 2017.

Last reviewed 2017-09-21 · How we verify

NCT03271593

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study

Completed Last updated 21 September 2017

What this trial tests

trial testing No intervention in Gastroenteritis in 1 participant. Completed in 23 September 2016.

Timeline

2 November 2015

Primary endpoint
23 September 2016

23 September 2016

Quick facts

Lead sponsor	GlaxoSmithKline
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1
Start date	2 November 2015
Primary completion	23 September 2016
Estimated completion	23 September 2016

Drugs / interventions tested

No intervention

Conditions studied

Gastroenteritis — all drugs for Gastroenteritis →

Sponsor

GlaxoSmithKline — full company profile →

Who can join

Under 15, any sex, with Gastroenteritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The impact of rotavirus vaccination on the burden of disease has been well documented. However, the anticipated reduction in hospital pressures has yet to be described. This study will provide quantitative measures of hospital pressure prior to and post vaccine introduction, provide a template for future hospital pressures studies related to vaccine introduction and provide measures which could be used in an economic evaluation.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Influenza-associated hospitalisation, vaccine uptake and socioeconomic deprivation in an English city region: an ecological study.
Hungerford D, Ibarz-Pavon A, Cleary P, French N. · · 2018 · cited 22× · PMID 30573483 · DOI 10.1136/bmjopen-2018-023275
Reduction in hospitalisations for acute gastroenteritis-associated childhood seizures since introduction of rotavirus vaccination: a time-series and change-point analysis of hospital admissions in England.
Hungerford DJ, French N, Iturriza-Gómara M, Read JM, et al · · 2019 · cited 11× · PMID 31511311 · DOI 10.1136/jech-2019-213055
Do hospital pressures change following rotavirus vaccine introduction? A retrospective database analysis in a large paediatric hospital in the UK.
Heinsbroek E, Hungerford D, Cooke RPD, Chowdhury M, et al · · 2019 · cited 6× · PMID 31097487 · DOI 10.1136/bmjopen-2018-027739

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Gastroenteritis

Currently open trials in the same condition.

NCT07285785 — Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea · Phase 4 · recruiting
NCT06579170 — Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada · active not recruiting
NCT05870150 — Challenge Non-Typhoidal Salmonella (CHANTS) Study · NA · active not recruiting
NCT04471493 — Pediatric and Ambulatory Research in Infectious Diseases · recruiting

Other GlaxoSmithKline trials

Trials by the same sponsor.

NCT07569081 — A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflam · Phase 2, PHASE3 · not yet recruiting
NCT07406347 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose · Phase 1 · not yet recruiting
NCT07286266 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEH · Phase 3 · not yet recruiting
NCT07286331 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-E · Phase 3 · not yet recruiting
NCT07406334 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03271593 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GlaxoSmithKline
Last refreshed: 21 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03271593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing